Back to Search Start Over

Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia.

Authors :
Kallas D
Roston TM
Franciosi S
Brett L
Lieve KVV
Kwok SY
Kannankeril PJ
Krahn AD
LaPage MJ
Etheridge S
Hill A
Johnsrude C
Perry J
Knight L
Fischbach P
Balaji S
Tisma-Dupanovic S
Law I
Atallah J
Backhoff D
Kamp A
Kubus P
Kean A
Aziz PF
Kovach J
Lau Y
Kron J
Clur SA
Sarquella-Brugada G
Wilde AAM
Sanatani S
Source :
Heart rhythm [Heart Rhythm] 2021 Nov; Vol. 18 (11), pp. 1825-1832. Date of Electronic Publication: 2021 Jul 29.
Publication Year :
2021

Abstract

Background: Children with catecholaminergic polymorphic ventricular tachycardia (CPVT) are at risk for sudden death, and a risk stratification tool does not exist.<br />Objective: The purpose of this study was to determine whether proband status, age at symptom onset, and/or sex are independent predictors of cardiac events.<br />Methods: A multicenter, ambispective, cohort of pediatric CPVT patients was categorized by sex, proband status, and age at symptom onset (D1: first decade of life [symptom onset <10 years] or D2: second decade of life [symptom onset 10-18 years, inclusive]). Demographics, therapy, genetics, and outcomes were compared between groups.<br />Results: A total of 133 patients were included and stratified into 58 D1 and 75 D2 patients (68 female and 65 male; 106 probands and 27 relatives). Localization of RYR2 variants to hotspots differed based on proband status and age at symptom onset. The cardiac event rate was 33% (n = 44/133), inclusive of a 3% (n = 4/133) mortality rate, over a median of 6 years (interquartile range 3-11) after time of symptom onset. Proband status, rather than age at of symptom onset or sex, was an independent predictor of time to first cardiac event (P = .008; hazard ratio = 4.4). The 5-, 10- and 15-year event-free survival rates for probands were 77%, 56%, and 46%, respectively, and for relatives were 96%, 91%, and 86%, respectively. Event risk after diagnosis was 48% (32/67) in patients on β-blocker or flecainide alone vs 10% (5/48) in patients on β-blocker plus flecainide and/or left cardiac sympathetic denervation (P <.001).<br />Conclusion: Proband status, but not age at symptom onset or male sex, independently predicted an earlier onset of cardiac events. A larger sample size would enable a comprehensive investigation of other risk factors.<br /> (Copyright © 2021 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1556-3871
Volume :
18
Issue :
11
Database :
MEDLINE
Journal :
Heart rhythm
Publication Type :
Academic Journal
Accession number :
34333088
Full Text :
https://doi.org/10.1016/j.hrthm.2021.07.061